Cliff has 25 years’ experience in the Pharmaceutical Industry, initially as a clinical researcher in MSDRL and GlaxoWellcome, followed by terms as a Decision Scientist at GSK and as Director/team Leader in the Portfolio & Decision Analysis Group at Pfizer. He has experience helping project teams make development decisions, and guiding budget holders and governance in allocating their scare budget and resource across a portfolio of opportunities.
Cliff is skilled at modelling business problems, both at a strategic and operational level. In 2011 he completed a MSc in Management Science at the University of Kent; his thesis was on R&D portfolio allocation modelling. His doctorate was in the field of physiological psychology.